Moussa BH Youdim

Presidente en Youdim Pharmaceuticals Ltd. .

Consumer Services

Finance

Commercial Services

Perfil

Moussa BH Youdim is currently the Director at MédiMabs, Inc. and the President, Chief Scientific Officer & Advisor at Youdim Pharmaceuticals Ltd.
He received his undergraduate, graduate, and doctorate degrees from McGill University.

Cargos activos de Moussa BH Youdim

Empresas	Cargo	Inicio
Youdim Pharmaceuticals Ltd. Youdim Pharmaceuticals Ltd. Investment ManagersFinance Youdim Pharmaceuticals Ltd (Youdim Pharmaceuticals) is a venture capital subsidiary of XT Investments Ltd founded in 1997. The firm is headquartered in Yokneam, Israel.	Presidente	01/04/2010
MédiMabs, Inc. MédiMabs, Inc. Miscellaneous Commercial ServicesCommercial Services MédiMabs, Inc. operates as a specialized boutique for antibodies and provides researchers with licensed products. It offers antigen design and strategy, polyclonal antibody development, Cryostorage, vaccine development and antibody validation services. The company was founded by A. Claudio Cuello in 2006 and is headquartered in Montreal, Canada.	Director/Miembro de la Junta	-

Todos los cargos activos de Moussa BH Youdim

Formación de Moussa BH Youdim.

McGill University

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Moussa BH Youdim.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Youdim Pharmaceuticals Ltd. Youdim Pharmaceuticals Ltd. Investment ManagersFinance Youdim Pharmaceuticals Ltd (Youdim Pharmaceuticals) is a venture capital subsidiary of XT Investments Ltd founded in 1997. The firm is headquartered in Yokneam, Israel.	Finance
MédiMabs, Inc. MédiMabs, Inc. Miscellaneous Commercial ServicesCommercial Services MédiMabs, Inc. operates as a specialized boutique for antibodies and provides researchers with licensed products. It offers antigen design and strategy, polyclonal antibody development, Cryostorage, vaccine development and antibody validation services. The company was founded by A. Claudio Cuello in 2006 and is headquartered in Montreal, Canada.	Commercial Services